- Investing Ideas
- South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks
South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
23
Mid-Large Cap Stocks
23 companies
PharmaResearch
Market Cap: ₩3.9t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩375,500.00
7D
10.0%
1Y
-33.8%
Yuhan
Market Cap: ₩5.3t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩70,700.00
7D
1.6%
1Y
-41.3%
Samsung BiologicsLtd
Market Cap: ₩71.7t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,549,000.00
7D
11.0%
1Y
-7.4%
D&D Pharmatech
Market Cap: ₩2.5t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩55,500.00
7D
-9.0%
1Y
67.3%
Hanall Biopharma
Market Cap: ₩2.3t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩45,200.00
7D
-6.1%
1Y
65.9%
SK bioscienceLtd
Market Cap: ₩2.7t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩33,800.00
7D
2.4%
1Y
-26.3%
Samsung Epis Holdings
Market Cap: ₩9.1t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩367,000.00
7D
-3.0%
1Y
n/a
Peptron
Market Cap: ₩3.3t
Engages in the development of peptide-based medicines.
A087010
₩143,000.00
7D
34.5%
1Y
-52.2%
NatureCellLtd
Market Cap: ₩1.5t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩23,250.00
7D
-6.1%
1Y
-22.2%
Hanmi Pharm
Market Cap: ₩4.8t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩374,500.00
7D
0.5%
1Y
33.3%
Celltrion Pharm
Market Cap: ₩1.8t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩39,900.00
7D
4.3%
1Y
-24.8%
ABL Bio
Market Cap: ₩3.9t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩68,800.00
7D
-0.7%
1Y
-11.7%
SK Biopharmaceuticals
Market Cap: ₩6.2t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩79,500.00
7D
2.4%
1Y
-21.2%
ALTEOGEN
Market Cap: ₩15.9t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩296,500.00
7D
8.6%
1Y
-35.0%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩237,500.00
7D
3.9%
1Y
-28.4%
Mezzion PharmaLtd
Market Cap: ₩1.7t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩56,900.00
7D
3.6%
1Y
47.2%
Caregen
Market Cap: ₩2.7t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩54,800.00
7D
-3.0%
1Y
7.2%
ST PharmLtd
Market Cap: ₩2.1t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩98,500.00
7D
-13.6%
1Y
12.6%
Sam Chun Dang Pharm
Market Cap: ₩3.3t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩139,500.00
7D
-16.9%
1Y
-39.6%
Celltrion
Market Cap: ₩40.7t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩177,400.00
7D
3.4%
1Y
4.2%
OliX Pharmaceuticals
Market Cap: ₩2.3t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩107,000.00
7D
-2.0%
1Y
129.9%
LigaChem Biosciences
Market Cap: ₩3.3t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩90,600.00
7D
-3.2%
1Y
-34.8%
Voronoi
Market Cap: ₩2.1t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩117,100.00
7D
-7.2%
1Y
-6.8%